Texas ChE Professor Jennifer Maynard and her research team have engineered “antibody-like” T cell receptors that can specifically stick to cells infected with cytomegalovirus, or CMV, a virus that causes lifelong infection in more than half of all adults by age 40. These receptors represent a new potential treatment option, could aid the development of … Read the rest »
“Antibody-like” T Cell Receptors May Be New Potential Treatment for Cytomegalovirus (#CMV) and Brain Tumors
Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
The enzyme, PEG-KYNase, does not directly kill cancer cells but instead empowers the immune system to eradicate unwanted cells on its own. PEG-KYNase is designed to degrade kynurenine, a metabolite produced by numerous tumors that … Read the rest »
AUSTIN, Texas — A team of chemical engineers at The University of Texas at Austin has developed a new, cost-effective method for synthetically producing a biorenewable platform chemical called triacetic acid lactone (TAL) that can be used to produce innovative new drugs and sustainable plastics at an industrial scale, as described this week in Proceedings … Read the rest »
The trade-off between membrane permeability and selectivity
Current studies on membrane permeability and selectivity show that improvements in the field could positively impact water filtration, treatment of waste products from fracking, and even climate change. But what challenges do engineers face when it comes to membranes? And what needs to be considered to make strides … Read the rest »